DIA conducting “10th Annual Meeting DIA JAPAN 2013” in tokyo 6th-8th Nov,2013
This conference, the main topic is what academia, regulatory agencies, industry, and patients could do better to move ahead with discovery and fostering of innovative drugs and also discussed
informative topis such as the role of ARO and issues surrounding companion diagnostics for cancer. Moreover, mainly focus on what we should do in the era of further globalized drug development from viewpoints of academia, regulatory, clinical and project management.
Makrocare is a global specialized consulting partner with extensive expertise in emerging region strategic design, regulatory compliance and governance, clinical, medical support and risk management planning. With operations and presence in US, UK, Europe & Asia, MakroCare is well positioned to meet the development & commercialization needs of life science industry globally.